Cargando…
A Bumpy and Winding but Right Path to Domestic Drug-Eluting Coronary Stents
Restenosis and stent thrombosis remain major concerns after percutaneous coronary intervention for the treatment of coronary artery disease. The present review was undertaken in order to highlight the various coronary stents that have been investigated in our Heart Research Center, and how far we ha...
Autores principales: | Cho, Jae Yeong, Ahn, Youngkeun, Jeong, Myung Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Society of Cardiology
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3831010/ https://www.ncbi.nlm.nih.gov/pubmed/24255648 http://dx.doi.org/10.4070/kcj.2013.43.10.645 |
Ejemplares similares
-
Drug-Eluting Stent as an Option for Intractable In-Stent Coronary Restenosis
por: Hachinohe, Daisuke, et al.
Publicado: (2011) -
Intravascular Ultrasound-Guided Treatment for In-stent Restenosis Associated with Stent Fracture in Overlapped Drug-eluting Stents
por: Kim, Min Chul, et al.
Publicado: (2019) -
Coronary Stent Thrombosis: Current Insights into New Drug-Eluting Stent Designs
por: Kim, Hyun Kuk, et al.
Publicado: (2012) -
Effectiveness of Drug-Eluting Stents versus Bare-Metal Stents in Large Coronary Arteries in Patients with Acute Myocardial Infarction
por: Sim, Doo Sun, et al.
Publicado: (2011) -
Comparison of bare metal stent and paclitaxel-eluting stent using a novel rat aorta stent model
por: Kwon, Jin Sook, et al.
Publicado: (2011)